Cargando…
Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study
BACKGROUND: Neuropsychological investigations can help untangle the aetiological and phenomenological heterogeneity of schizophrenia but have scarcely been employed in the context of treatment-resistant (TR) schizophrenia. No population-based study has examined neuropsychological function in the fir...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712950/ https://www.ncbi.nlm.nih.gov/pubmed/30348234 http://dx.doi.org/10.1017/S0033291718002957 |
_version_ | 1783446786786983936 |
---|---|
author | Kravariti, Eugenia Demjaha, Arsime Zanelli, Jolanta Ibrahim, Fowzia Wise, Catherine MacCabe, James H. Reichenberg, Abraham Pilecka, Izabela Morgan, Kevin Fearon, Paul Morgan, Craig Doody, Gillian A. Donoghue, Kim Jones, Peter B. Kaçar, Anil Şafak Dazzan, Paola Lappin, Julia Murray, Robin M. |
author_facet | Kravariti, Eugenia Demjaha, Arsime Zanelli, Jolanta Ibrahim, Fowzia Wise, Catherine MacCabe, James H. Reichenberg, Abraham Pilecka, Izabela Morgan, Kevin Fearon, Paul Morgan, Craig Doody, Gillian A. Donoghue, Kim Jones, Peter B. Kaçar, Anil Şafak Dazzan, Paola Lappin, Julia Murray, Robin M. |
author_sort | Kravariti, Eugenia |
collection | PubMed |
description | BACKGROUND: Neuropsychological investigations can help untangle the aetiological and phenomenological heterogeneity of schizophrenia but have scarcely been employed in the context of treatment-resistant (TR) schizophrenia. No population-based study has examined neuropsychological function in the first-episode of TR psychosis. METHODS: We report baseline neuropsychological findings from a longitudinal, population-based study of first-episode psychosis, which followed up cases from index admission to 10 years. At the 10-year follow up patients were classified as treatment responsive or TR after reconstructing their entire case histories. Of 145 cases with neuropsychological data at baseline, 113 were classified as treatment responsive, and 32 as TR at the 10-year follow-up. RESULTS: Compared with 257 community controls, both case groups showed baseline deficits in three composite neuropsychological scores, derived from principal component analysis: verbal intelligence and fluency, visuospatial ability and executive function, and verbal memory and learning (p values⩽0.001). Compared with treatment responders, TR cases showed deficits in verbal intelligence and fluency, both in the extended psychosis sample (t = −2.32; p = 0.022) and in the schizophrenia diagnostic subgroup (t = −2.49; p = 0.017). Similar relative deficits in the TR cases emerged in sub-/sensitivity analyses excluding patients with delayed-onset treatment resistance (p values<0.01–0.001) and those born outside the UK (p values<0.05). CONCLUSIONS: Verbal intelligence and fluency are impaired in patients with TR psychosis compared with those who respond to treatment. This differential is already detectable – at a group level – at the first illness episode, supporting the conceptualisation of TR psychosis as a severe, pathogenically distinct variant, embedded in aberrant neurodevelopmental processes. |
format | Online Article Text |
id | pubmed-6712950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-67129502019-09-05 Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study Kravariti, Eugenia Demjaha, Arsime Zanelli, Jolanta Ibrahim, Fowzia Wise, Catherine MacCabe, James H. Reichenberg, Abraham Pilecka, Izabela Morgan, Kevin Fearon, Paul Morgan, Craig Doody, Gillian A. Donoghue, Kim Jones, Peter B. Kaçar, Anil Şafak Dazzan, Paola Lappin, Julia Murray, Robin M. Psychol Med Original Articles BACKGROUND: Neuropsychological investigations can help untangle the aetiological and phenomenological heterogeneity of schizophrenia but have scarcely been employed in the context of treatment-resistant (TR) schizophrenia. No population-based study has examined neuropsychological function in the first-episode of TR psychosis. METHODS: We report baseline neuropsychological findings from a longitudinal, population-based study of first-episode psychosis, which followed up cases from index admission to 10 years. At the 10-year follow up patients were classified as treatment responsive or TR after reconstructing their entire case histories. Of 145 cases with neuropsychological data at baseline, 113 were classified as treatment responsive, and 32 as TR at the 10-year follow-up. RESULTS: Compared with 257 community controls, both case groups showed baseline deficits in three composite neuropsychological scores, derived from principal component analysis: verbal intelligence and fluency, visuospatial ability and executive function, and verbal memory and learning (p values⩽0.001). Compared with treatment responders, TR cases showed deficits in verbal intelligence and fluency, both in the extended psychosis sample (t = −2.32; p = 0.022) and in the schizophrenia diagnostic subgroup (t = −2.49; p = 0.017). Similar relative deficits in the TR cases emerged in sub-/sensitivity analyses excluding patients with delayed-onset treatment resistance (p values<0.01–0.001) and those born outside the UK (p values<0.05). CONCLUSIONS: Verbal intelligence and fluency are impaired in patients with TR psychosis compared with those who respond to treatment. This differential is already detectable – at a group level – at the first illness episode, supporting the conceptualisation of TR psychosis as a severe, pathogenically distinct variant, embedded in aberrant neurodevelopmental processes. Cambridge University Press 2019-09 2018-10-23 /pmc/articles/PMC6712950/ /pubmed/30348234 http://dx.doi.org/10.1017/S0033291718002957 Text en © Cambridge University Press 2018 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Kravariti, Eugenia Demjaha, Arsime Zanelli, Jolanta Ibrahim, Fowzia Wise, Catherine MacCabe, James H. Reichenberg, Abraham Pilecka, Izabela Morgan, Kevin Fearon, Paul Morgan, Craig Doody, Gillian A. Donoghue, Kim Jones, Peter B. Kaçar, Anil Şafak Dazzan, Paola Lappin, Julia Murray, Robin M. Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study |
title | Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study |
title_full | Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study |
title_fullStr | Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study |
title_full_unstemmed | Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study |
title_short | Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study |
title_sort | neuropsychological function at first episode in treatment-resistant psychosis: findings from the æsop-10 study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712950/ https://www.ncbi.nlm.nih.gov/pubmed/30348234 http://dx.doi.org/10.1017/S0033291718002957 |
work_keys_str_mv | AT kravaritieugenia neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT demjahaarsime neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT zanellijolanta neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT ibrahimfowzia neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT wisecatherine neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT maccabejamesh neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT reichenbergabraham neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT pileckaizabela neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT morgankevin neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT fearonpaul neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT morgancraig neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT doodygilliana neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT donoghuekim neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT jonespeterb neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT kacaranilsafak neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT dazzanpaola neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT lappinjulia neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study AT murrayrobinm neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study |